Personalized Natural Killer Cell Therapy
Personalized NK Cell Therapy After Chemotherapy and Cord Blood Transplant in Treating Patients With Myelodysplastic Syndrome, Leukemia, Lymphoma or Multiple Myeloma
Arms / Cohorts
Experimental Arm 1:Myeloma Patients: Myeloablative Regimen 1
Accepting patients
Experimental Arm:Myeloma Patients: Non-myeloablative Regimen 2
Accepting patients
Experimental Arm:Myeloma Patients: Reduced Intensity Regimen 3
Accepting patients
MDS Patients: Myeloablative Regimen 1
Accepting patients
MDS Patients: Non-myeloablative Regimen 2
Accepting patients
MDS Patients: Reduced Intensity Regimen 3
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.